You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中珠醫療(600568.SH)2019年業績預虧 虧損收窄至3-4.5億元
格隆匯 01-17 16:58

格隆匯1月17日丨中珠醫療(600568.SH)發佈2019年年度業績預告,預計2019年年度實現歸屬於上市公司股東的淨利潤將出現虧損,實現歸屬於上市公司股東的淨虧損3億元-虧損4.5億元,去年同期則為淨虧損18.95億元。歸屬於上市公司股東扣除非經常性損益後的淨虧損3億元到-虧損4.2億元,去年同期則為淨虧損15.02億元

報告期內,受國家宏觀調控和房產政策影響,房地產業務收入比上年同期有部分幅度減少,造成利潤減少。其他醫療器械和腫瘤中心等業務板塊正處於投入恢復階段,均有提升,但由於基數太小,對公司整體毛利貢獻度很小。

期內,對浙江愛德醫院收購定金5000萬元去年已經計提信用減值損失2500萬元,今年根據訴訟進展情況預計需繼續計提2500萬元。對公司戰略調整期間出售公司原子公司時候形成的中珠集團及其關聯方對公司欠款未按期收回,且收回風險較大時間較長,預計需計提壞賬準備1.9億元。對長期未收回的應收款項預計信用減值損失約4000萬,處置中心舊資產損失約1300萬元,其他部分資產減值損失約2500萬元

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account